Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
204 participants
OBSERVATIONAL
2013-09-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The significance of time to recompression is controversial. It has been suggested that early hyperbaric treatment improves the outcome by decreasing bubble size and avoiding further tissue injury. However, in recent studies time to recompression had very little effect on clinical recovery. Moreover, the time beyond which hyperbaric treatment isn't effective has not been determined yet.
The aim of this study was to evaluate the clinical outcome of delayed hyperbaric treatment to divers who referred to tertiary care hospital hyperbaric unit, more than 48 hours after surfacing. The clinical outcome of the delayed hyperbaric treatments was compared to early treatments given at the same hyperbaric unit.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Hyperoxia and Involvement of the Immune System in Diving Accident
NCT04791488
Angiogenesis Induced in the Elderly by Hyperbaric Oxygen Therapy
NCT02790541
Microcirculatory Perfusion in Patients With Coma After Out-of-hospital Cardiac Arrest
NCT01850485
Efficacy and Pathophysiological Implications of a New Asphyxiation Delaying Device
NCT05779540
Effect of Hyperbaric Oxygen Therapy on Microcirculation
NCT03980210
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The data will be collected retrospectively from medical records and include age, sex, diving experience, maximal depth, DCS possible cause, DCS type, symptoms, time from surfacing to symptoms onset, time from surfacing to recompression, recompression table, additional treatment after the first recompression and treatment outcome.
Statistical analysis will be done using univariant analysis was performed using Spearman's correlation and Chi-Square in categoric variabales, independent t-test in numeric variables. This will be performed in SPSS v.21 software.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Delayed
Time from surfacing to recompression \>=48 hours
No interventions assigned to this group
Early
Time from surfacing to recompression \<48 hours
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Recompression Treatment between 2000-2014 in Assaf HaRofe medical center hyperbaric institute
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assaf-Harofeh Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shai Efrati, MD
Role: STUDY_CHAIR
Assaf Harofe Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assaf-Harofeh Medical Center
Ẕerifin, Israel, Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
134/13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.